These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32636658)

  • 1. Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study.
    Pei F; Zhang GR; Zhou LX; Liu JY; Ma G; Kou QY; He ZJ; Chen MY; Nie Y; Wu JF; Guan XD;
    Infect Drug Resist; 2020; 13():2053-2061. PubMed ID: 32636658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
    Joshi I; Carney WP; Rock EP
    Front Immunol; 2023; 14():1130214. PubMed ID: 36825018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit.
    Manzoli TF; Troster EJ; Ferranti JF; Sales MM
    J Crit Care; 2016 Jun; 33():84-9. PubMed ID: 26928303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoparalysis in critically ill children.
    Neves FL; Amaral MNGA; da Silva SFD; Silva IMM; Laranjeira PMDS; Pinto CRJ; Paiva AA; Dias ASDS; Coelho MLACV
    Immunology; 2023 Apr; 168(4):597-609. PubMed ID: 36279244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
    Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
    Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma.
    Cheron A; Floccard B; Allaouchiche B; Guignant C; Poitevin F; Malcus C; Crozon J; Faure A; Guillaume C; Marcotte G; Vulliez A; Monneuse O; Monneret G
    Crit Care; 2010; 14(6):R208. PubMed ID: 21092108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis.
    Bline KE; Moore-Clingenpeel M; Hensley J; Steele L; Greathouse K; Anglim L; Hanson-Huber L; Nateri J; Muszynski JA; Ramilo O; Hall MW
    Crit Care; 2020 Sep; 24(1):545. PubMed ID: 32887651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis.
    Wu JF; Ma J; Chen J; Ou-Yang B; Chen MY; Li LF; Liu YJ; Lin AH; Guan XD
    Crit Care; 2011; 15(5):R220. PubMed ID: 21933399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma.
    Gouel-Chéron A; Allaouchiche B; Guignant C; Davin F; Floccard B; Monneret G;
    PLoS One; 2012; 7(3):e33095. PubMed ID: 22431998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.
    Landelle C; Lepape A; Voirin N; Tognet E; Venet F; Bohé J; Vanhems P; Monneret G
    Intensive Care Med; 2010 Nov; 36(11):1859-66. PubMed ID: 20652682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.
    Monneret G; Debard AL; Venet F; Bohe J; Hequet O; Bienvenu J; Lepape A
    Crit Care Med; 2003 Jul; 31(7):2068-71. PubMed ID: 12847405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.
    Monneret G; Lepape A; Voirin N; Bohé J; Venet F; Debard AL; Thizy H; Bienvenu J; Gueyffier F; Vanhems P
    Intensive Care Med; 2006 Aug; 32(8):1175-83. PubMed ID: 16741700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction is Associated With an Immune Paralysis Phenotype in Pediatric Sepsis.
    Weiss SL; Zhang D; Bush J; Graham K; Starr J; Murray J; Tuluc F; Henrickson S; Deutschman CS; Becker L; McGowan FX; Wallace DC
    Shock; 2020 Sep; 54(3):285-293. PubMed ID: 31764621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac steroid ouabain transcriptionally increases human leukocyte antigen DR expression on monocytes.
    Chen L; Zhang M; Wang X; Liu Y; Bian J; Yan D; Yin W
    Steroids; 2021 Nov; 175():108915. PubMed ID: 34508735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction.
    Lukaszewicz AC; Grienay M; Resche-Rigon M; Pirracchio R; Faivre V; Boval B; Payen D
    Crit Care Med; 2009 Oct; 37(10):2746-52. PubMed ID: 19707128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients.
    Fang WF; Douglas IS; Chen YM; Lin CY; Kao HC; Fang YT; Huang CH; Chang YT; Huang KT; Wang YH; Wang CC; Lin MC
    PLoS One; 2017; 12(10):e0187088. PubMed ID: 29073262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial.
    Leventogiannis K; Kyriazopoulou E; Antonakos N; Kotsaki A; Tsangaris I; Markopoulou D; Grondman I; Rovina N; Theodorou V; Antoniadou E; Koutsodimitropoulos I; Dalekos G; Vlachogianni G; Akinosoglou K; Koulouras V; Komnos A; Kontopoulou T; Prekates A; Koutsoukou A; van der Meer JWM; Dimopoulos G; Kyprianou M; Netea MG; Giamarellos-Bourboulis EJ
    Cell Rep Med; 2022 Nov; 3(11):100817. PubMed ID: 36384100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes.
    Leijte GP; Rimmelé T; Kox M; Bruse N; Monard C; Gossez M; Monneret G; Pickkers P; Venet F
    Crit Care; 2020 Mar; 24(1):110. PubMed ID: 32192532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte Trajectories Endotypes Are Associated With Worsening in Septic Patients.
    Bodinier M; Peronnet E; Brengel-Pesce K; Conti F; Rimmelé T; Textoris J; Vedrine C; Quemeneur L; Griffiths AD; Tan LK; Venet F; Maucort-Boulch D; Monneret G;
    Front Immunol; 2021; 12():795052. PubMed ID: 34912347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoparalysis: Clinical and immunological associations in SIRS and severe sepsis patients.
    Papadopoulos P; Pistiki A; Theodorakopoulou M; Christodoulopoulou T; Damoraki G; Goukos D; Briassouli E; Dimopoulou I; Armaganidis A; Nanas S; Briassoulis G; Tsiodras S
    Cytokine; 2017 Apr; 92():83-92. PubMed ID: 28119177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.